$1.19
-0.06-4.80%
At Close: -
$1.27
0.086.72%
After Hours: Aug 20, 7:01 AM EDT
15 minutes delayed
Barinthus Biotherapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Barinthus Biotherapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-08 | $-0.43 | $-0.41 | -4.88 % |
Mar 2024 | 2024-05-13 | $-0.40 | $-0.54 | 25.9 % |
Dec 2023 | 2024-03-20 | $-0.45 | $-0.50 | 10.0 % |
Sep 2023 | 2023-11-09 | $-0.37 | $-0.53 | 30.2 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Mar 2024 | 2024-05-13 | $0 | $130.00K | -100.0 % |
Dec 2023 | 2024-03-20 | $0 | $130.00K | -100.0 % |
Jun 2023 | 2023-08-10 | $334.00K | $600.00K | -44.3 % |
Mar 2023 | 2023-05-12 | $468.00K | $1.50M | -68.8 % |
Barinthus Biotherapeutics (BRNS) is scheduled to report earnings on November 7, 2024. The last reported earnings were for reported on August 8, 2024 for Q2.
The Actual EPS was $-0.43, which missed the estimate of $-0.41.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.